Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mitral regurgitation
MedTech
Abbott snags US approval for mitral valve replacement implant
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify patients for other approaches.
Conor Hale
May 27, 2025 10:30am
Abbott’s MitraClip shows gains in functional-yet-leaky valves
Aug 31, 2024 6:00am
Capstan Medical nets $31M for robotic heart valve replacement
Aug 10, 2023 10:40am
TMVR maker 4C Medical scores $35M and a new CEO to boot
Mar 31, 2022 4:10pm
InnovHeart nabs J&J, Haemonetics alum as CEO
Mar 30, 2022 11:28am
InnovHeart lands $55M to take TMVR system to clinical trials
Jan 27, 2022 11:50am
